Abstract
Introduction
The regulation of intracellular [Ca 2+ ]i is important for all cells, but in particular for smooth muscle, as [Ca 2+ ]i is a key second messenger leading to contraction. Mechanisms for clearance of [Ca 2+ ]i form one side of Ca 2+ homeostasis and include: Plasma Membrane Ca 2+ ATPases (PMCA), Sarcoplasmic/Endoplasmic Reticulum Ca 2+ ATPases (SERCA), Na + -Ca 2+ -exchangers (NCX) when coupled to the Na + -K + ATPases (NKA) and in some cases mitochondria (Fig. 1 ).
The nature and relative contribution of these various components of cytosolic Ca 2+ clearance have long been an important topic for study in smooth muscle (Casteels et al., 1986; Rüegg, 1988; Somlyo and Himpens, 1989; Daniel et al., 1995; Karaki et al., 1997; Zderic et al., 1999; Sanders, 2001; Karaki, 2004) .
Studies to Ca 2+ clearance generally involve inhibition of one or more of these components and investigating the consequences on [Ca 2+ ]i or more typically, contractility. Our knowledge has advanced considerably with the development of specific inhibitors, such as cyclopiazonic acid (Luo et al., 1993) , thapsigargin (Bian et al., 1991) and BHQ (Papp et al., 1992) for SERCA.
Inhibition of the other components is less satisfactory. NCX is often inhibited by replacing extracellular Na + or using the reverse mode inhibitor, KB-R7943, or forward mode inhibitor, SEA0400 (Iwamoto and Kita, 2004) . The relatively large change in terms of ionic balances in the former, and specificity of the latter are drawbacks to NCX inhibition (Reuter et al., 2002) . NKA can be very specifically inhibited by ouabain, and thus the coupled NKA-NCX Ca 2+ extrusion pathway, but again changes in many factors, including membrane potential and other processes linked to NKA, such as Na + -H + exchange also change. Specific inhibitors of PMCA are even more limited. Orthovanadate, which inhibits all P-type ATPases been used, but has limited specificity (Tiffert and Lew, 2001 
Plasma membrane Ca 2+ pumps
Four PMCA isoforms (PMCA1-4) are currently known and a number of splice variants have also been reported (Strehler and Zacharias, 2001 ). PMCA1 and PMCA4 are ubiquitously expressed and are the only isoforms to date reported for smooth muscle, with the possible exception that PMCA2b has been reported for uterus (Penniston and Enyedi, 1998) . Due to their widespread distribution, they are thought to be important "housekeeping" Ca 2+ -pumps, but their function in smooth muscle is less well known. In addition to Ca 2+ homeostasis, it has been suggested that PMCA is associated with vascular smooth muscle proliferation (Abramowitz et al., 2000) and signal transduction (Hammes et al., 1998) . The latter is based on the PDZ domains in PMCA4b which lead to a complex with nitric oxide synthase I in caveolae of vascular smooth muscle (Schuh et al., 2001) . PMCA gene-altered mice to date include gene-targeted PMCA1 , PMCA4 Schuh et al., 2004) and mice expressing PMCA4 using smooth muscle specific promoters (Gros et al., 2003; Schuh et al., 2003) . At the level of PMCA mRNA message in mouse aorta, PMCA1 is reported to be approximately twice that of PMCA4, which is reversed in the PMCA4 smooth muscle specific transgenic. Using a generalized promoter for expression of PMCA1, SERCA expression was reported to be downregulated, whereas high levels of Ca 2+ tended to lead to greater expression of both (Kuo et al., 1997) .
The role of PMCA in relaxation of force and by implication, Ca 2+ clearance, appears to depend on the type of smooth muscle tissue. In uterus from PMCA4 gene-targeted mice, PMCA was reported to account for 70% of the rate of force reduction compared to about 10% for NCX (Matthew et al., 2004) . On the other hand, we have found using the PMCA1-4 double genetargeted mouse bladder, that PMCA accounts for approximately 25% with NCX being the dominant player (Liu et al., 2005) . Gene-targeting of PMCA4 in portal vein, in contrast, led to an apoptosis phenotype in vitro, indicating the loss of PMCA4 could lead to Ca 2+ overload and apoptotic cell death in some cases . Surprisingly, the phenomenon appeared to be dependent on the genetic background of the mouse .
Treatment with PMCA antisense oligonucleotides was also reported to elicit apoptosis of rat aortic smooth muscle cells (Sasamura et al., 2002) . Smooth muscle specific expression of PMCA4 led somewhat paradoxically to an increase in blood pressure. An increased force response to KCl was reported for the aorta, (Schuh et al., 2003) ; but was not observed in mesenteric resistance vessels (Gros et al., 2003) . The increase in blood pressure and force was attributed to the close association of nNOS and PMCA4 in caveolae, leading to lower local Ca 2+ and nitric oxide production by both groups. One of the more interesting developments in Ca 2+ clearance is this growing realization the intracellular localization, such as PMCA to caveolae (Fujimoto, 1993) , may play special roles in Ca   2+ signaling. The close apposition of caveolae to some superficial sarcoplasmic reticulum has been suggested to be involved with local IP3-mediated SR Ca 2+ -release (Taggart, 2001) , as well as potential vectorial unloading of the SR (Lee et al., 2002) .
Sarcoplasmic/endoplasmic reticulum Ca 2+ pumps
Studies of the role of SERCA in Ca 2+ clearance in smooth muscle have a long history and range through the gamut from minimal to crucial (Eisner, 2002) . The splice variants SERCA2a and 2b are the only reported isoforms of SERCA in smooth muscle. Two gene-targeted mice have been reported, a heterozygous (the homozygous null is embryonically lethal) KO of SERCA2 and a KO of SERCA2a (Ver Heyen et al., 2001) . While cardiac function of these gene-targeted mice has been intensively studied , smooth muscle studies are limited. We investigated aortic contractility and though like the heart, SERCA was reduced by about 50%, there were no changes in contraction to phenylephrine ( Fig.   2A ) or KCl, and no difference in relaxation to A-kinase pathway (forskolin; Fig. 2B ) or G-kinase pathway activation (sodium nitroprusside) (Weber et al., 1999) . This was quite surprising, given the major effects of the endogenous inhibitor, phospholamban (PLN, see below). To our knowledge there are no reported smooth muscle studies of the SERCA2a gene-targeted mouse.
Though not smooth muscle, it is also worth noting, that gene-targeting of SERCA3, an isoform found in vascular endothelium (Liu et al., 1997) , and PLN both affected endothelium-dependent relaxation of aorta. In contrast to the limited effects of reduction in SERCA protein by genetic manipulation, modulation of SERCA activity by genetic manipulation of PLN has major cardiac (Chu et al., 2002) and smooth muscle effects (Paul et al., 2002) . We first reported that aorta from the PLN-KO mouse were less sensitive in terms of their stimulus-force relations (Lalli et al., 1997) , which was also reflected in the stimulus-[Ca 2+ ]i relations (Lalli et al., 1999) . A similar rightward shift was also observed for bladder (Nobe et al., 2001) . Treatment with the SERCA inhibitor cyclopiazonic acid (CPA) normalized the wild-type and PLN-KO behavior. After CPA treatment similar stimulus-response relationships for both were observed, suggesting that the only functional alteration was at the level of the SR. Expression of a PLN transgene using the smooth Post stimulation to 80% of maximum force with PE, cumulative forskolin-force relation. Maximum force was identical. Reduction of SERCA protein by 50% had no effect. Mean ± SEM (n=3-4).
muscle α-actin promoter lead to more sensitive Ca 2+ and force responses. This increased sensitivity in force generation was not further affected by CPA, the opposite of that seen in the PLN-KO. We suggest that this was due to maximum inhibition of SERCA by the expressed PLN (Nobe et al., 2001) , such that further inhibition by CPA was not effective. We suggested that the rightward shift in these responses in PLN-KO smooth muscles was due to disinhibition of SERCA and SR Ca 2+ -uptake, leading to less [Ca 2+ ]i and force for any given stimulus and Ca
2+
input.
An alternative hypothesis for these mechanical effects might be ascribable to a more hyperpolarized membrane potential in the PLN-KO. Increased loading of the SR due to uninhibited SERCA activity in the absence of PLN may lead to enhanced "Ca 2+ spark" production. In smooth muscle, enhanced Ca 2+ sparks may lead to hyperpolarization due to activation of KCa channels (Imaizumi et al., 1998; Jaggar et al., 2000) . Increased spark activity has been reported for cerebral arteries from the PLN-KO mouse (Wellman et al., 2001 ) and could account for baseline differences. It is not clear why inhibition of SERCA with increased PLN expression has significant smooth muscle effects, but reduction of SERCA expression by 50% in the SERCA2 heterozygous null had little. Estimation of the PLN:SERCA stoichiometry is difficult. For cardiac muscle, functional evidence suggests that 40% of SERCA is associated with PLN (Brittsan et al., 2000) .
Given that expression of PLN had significant effects suggests that in bladder smooth muscle, all SERCA was not associated with PLN. Perhaps there is a reserve of SERCA, not associated with PLN that remains active. The role of Na + -Ca 2+ -exchanger (NCX) and Na + -K + ATPase (NKA) in smooth muscle function has long been investigated particularly on cardiovascular and digestive physiology since the discovery of the inhibitory action of cardiac glycosides on NKA (Schatzmann, 1953) and the proposal for a prototype NCX (Niedergerke, 1963) . Earlier works based on 45 Ca flux measurements suggest the contributions of reverse mode (Na + out, Ca 2+ in) of NCX to tension maintenance (Pfaffman et al., 1965) , and forward mode (Ca 2+ out, Na + in) to ouabain-induced relaxation of the taenia caeci (Shimo et al., 1968) . Co-localization of NCX and NKA on the plasma membrane near superficial SR (ER) has been shown using immunohistological methods (Blaustein and Lederer, 1999; Poburko et al., 2004) , as described below. Therefore, NCX and NKA are capable of functioning cooperatively together with SERCA.
A difficulty with trying to assess the role of NCX/NKA is that it can vary dramatically from one smooth muscle tissue to another. As shown in Fig. 3A , inhibition of NCX by replacement of Na + with methylglucosamine nearly blocks phenylephrine contraction in mouse aorta. This may indicate that NCX operating in the reverse direction is necessary for loading Ca 2+ into the SR.
For bladder (Fig. 3B) , on the other hand, the acetylcholine-peak force relation is only moderately right-shifted. Similarly for uterus (Matthew et al., 2004) and airway (Janssen et al., 1999 ) the contribution of NCX to Ca 2+ extrusion is estimated to be 10% or less.
The role of NCX is very important to vascular function and it has been implicated as the major player in salt-sensitive hypertension (Iwamoto et al., 2004) . In aortic cells isolated from the spontaneously hypertensive rat, both protein and mRNA expressions for NCX1 were upregulated and angiotensin II increased 45 Ca efflux via NCX, when compared with those from WKY rat (Taniguchi et al., 2004) . Wakimoto et al. (2000) reported that both tension and 45 Ca uptake simulated in Na + -free conditions (reverse mode) were attenuated in the aorta of the heterozygous Ncx1 (+/-) mouse. In addition, homozygous mutation of Ncx/Hox11L.1 produced mega-ileo-ceco-colon in the proximal colon, presumably due to the bowel motility dysfunction associated with an altered acetylcholine sensitivity of smooth muscle (Yanai et al., 2004) .
The mammalian NCX family comprises three isoforms NCX1-3 and numerous splice variants (Philipson and Nicoll, 2000) . The heart exclusively expresses NCX1.1 and vascular tissue predominantly NCX1.3 and NCX1.7 (Quednau et al., 1997) . Membrane potential and transmembrane gradients of Na + and Ca 2+ control the bidirectional NCX with the ultimate driving force being NKA. A mechanism for β-adrenergic relaxation was based on stimulation of NKA and coupled NCX extrusion of Ca 2+ (Scheid et al., 1979) . So in a sense, NKA can also be counted among the players in Ca 2+ clearance. There are 4 known isoforms of the main α-NKA subunit, with α1 and α2 associated with mouse smooth muscle (Lingrel et al., 2003; Shelly et al., 2004) . In rodents, these isoforms are distinguished by the relative sensitivity to inhibition by ouabain, with α2 >> α1. While it has been known for some time that NCX and NKA co-localize in smooth muscle (Moore et al., 1993) , recent evidence from cultured astrocytes has shown that the α1 and α2 NKA isoforms display distinct localization (Juhaszova and Blaustein, 1997) ; the α1 isoform being more widely distributed while the α2 shows a punctuate distribution. Blaustein and colleagues (Blaustein and Lederer, 1999; Blaustein et al., 2002) proposed that the α2 isoform controlled Ca 2+ via NCX in a subcompartment communicating with SERCA, and thus modulating SR Ca 2+ loading and contractility.
Gene-targeted NKA α1-and α2-isoform mice have been developed (James et al., 1999) . The homozygous null is lethal for both isoforms, but the α2 -/-mice are born, but die shortly thereafter. We have used the neonate α2 -/-mice to test the hypothesis that these isoforms had distinct functional roles (Shelly et al., 2004) . Since the α1:α2 distribution in the aorta is 70:30, the total NKA in α1 +/-and α2 -/-would be similar. However, whereas contractility in the α1 +/-aorta was similar to the wild-type, the α2 -/-was more sensitive to contractile agonists and less sensitive to A-or G-kinase mediated relaxation pathways. We have also developed mice expressing the α1-and α2-isoforms in smooth muscle. Our preliminary findings are that while the mouse carrying the transgene for α1 is normotensive, the α2 expressing mouse is hypotensive (Staton et al., 2004) . Recently Lingrel and colleagues (Dostanic et al., 2005) have produced a novel NKA isoform "knock in" mouse to further test isoform specificity. They used gene-targeting to replace the ouabain-sensitive α2 isoform with a modified, ouabain-insensitive mouse. This mouse was resistant to ouabain-induced hypertension, suggesting that this isoform may be the receptor for hypertension developed in response to the so-called endogenous digitalis-like factor (EDLF).
Ca

2+ clearance overview
As is not untypical of studies on gene-altered mice, it is often the new questions raised rather than answers they bring. This is particulary true as we are rapidly learning that the individual components of Ca 2+ homeostasis are rarely independent. There are reports of ties between SERCA and PMCA, and SERCA and NCX via the NKA α2-isoform, and SERCA, Ca 2+ sparks and KCa channels to name just a few. Thus the value of genetically-altered mice also lies in determining the mechanisms of genetic homeostatic responses to each altered component of Ca 2+ clearance. For example, different isoforms do not appear to substitute for one another, at least at the protein level. The ablation of PMCA4, for example, was not accompanied by upregulation of PMCA1, nor was the α2 NKA isoform upregulated to replace the ablated α1 isoform, the SERCA isoforms also follow this non-substitution pattern. On the other hand, at least for cardiac muscle, it has been reported that a decrease in NKA leads to an upregulation in NCX and vice versa (Magyar et al., 1995) . Somewhat paradoxically, when we expressed PLN, SERCA decreased, the opposite of what one might expect if preservation of total SERCA activity was to be maintained (Nobe et al., 2001) . A parallel finding was reported for cardiac muscle except in reverse, so that in the SERCA +/-heart, PLN was increased . The nature of the potential interactions including spatial co-localization of these Ca 2+ clearance components and the possibility of coordinated expression amongst these components remains to be explored. Bolton, T.B. (1998 
